Temporal Colonic Gene Expression Profiling in the Recurrent Colitis Model Identifies Early and Chronic Inflammatory Processes

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Kremer, Bas ^a   Mariman, Rob ^a,b   van Erk, Marjan ^a   Lagerweij, Tonny ^a   Nagelkerken, Lex ^a  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; CALGRANULIN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CXCL14 CHEMOKINE; CXCL15 CHEMOKINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN S 100; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CHRONIC DISEASE; COLITIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE NUMBER; HISTOPATHOLOGY; IMMUNE RESPONSE; MAST CELL; NONHUMAN; PATHOGENESIS; RAT; RECURRENT DISEASE; UPREGULATION;

ADMINISTRATION, RECTAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CHRONIC DISEASE; COLITIS; COLON; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOMODULATION; INFLAMMATION; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TH1-TH2 BALANCE; TIME FACTORS; TRANSCRIPTOME; TRINITROBENZENESULFONIC ACID;

MUS;

EID: 84870583092     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050388     Document Type: Article

References (46)

1. Engel MA, Neurath MF, (2010) New pathophysiological insights and modern treatment of IBD. Journal of Gastroenterology 45: 571-583.
2. Xavier RJ, Podolsky DK, (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
3. Kozuch PL, Hanauer SB, (2008) Treatment of inflammatory bowel disease: A review of medical therapy. World Journal of Gastroenterology: WJG 14: 354-377.
4. Kawada M, Arihiro A, Mizoguchi E, (2007) Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World Journal of Gastroenterology: WJG 13: 5581-5593.
5. Wirtz S, Neufert C, Weigmann B, Neurath MF, (2007) Chemically induced mouse models of intestinal inflammation. Nature Protocols 2: 541-546.
6. Neurath M, Fuss I, Strober W, (2000) TNBS-colitis. International Reviews of Immunology 19: 51-62.
7. Paiotti AP, Miszputen SJ, Oshima CT, Artigiani Neto R, Ribeiro DA, et al. (2011) Etanercept attenuates TNBS-induced experimental colitis: Role of TNF-alpha expression. Journal of Molecular Histology 42: 443-450.
8. Shen C, de Hertogh G, Bullens DM, Van Assche G, Geboes K, et al. (2007) Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: Mechanisms beyond neutralization? Inflammatory Bowel Diseases 13: 308-316.
9. Mencarelli A, Renga B, Palladino G, Distrutti E, Fiorucci S, (2009) The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. Biochemical Pharmacology 78: 1214-1223.
10. Elson CO, Cong Y, Lorenz R, Weaver CT, (2004) New developments in experimental models of inflammatory bowel disease. Current Opinion in Gastroenterology 20: 360-367.
11. Strober W, Fuss IJ, (2006) Experimental models of mucosal inflammation. Advances in Experimental Medicine and Biology 579: 55-97.
12. Fichtner-Feigl S, Fuss IJ, Preiss JC, Strober W, Kitani A, (2005) Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. The Journal of Clinical Investigation 115: 3057-3071.
13. Lawrance IC, Wu F, Leite AZ, Willis J, West GA, et al. (2003) A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology. 125: 1750-1761.
14. Fichtner-Feigl S, Strober W, Geissler EK, Schlitt HJ, (2008) Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis. Mucosal Immunology 1 (Suppl 1): S24-7.
15. Fichtner-Feigl S, Fuss IJ, Young CA, Watanabe T, Geissler EK, et al. (2007) Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. Journal of Immunology (Baltimore, Md.: 1950) 178: 5859-5870.
16. Mariman R, Kremer B, van Erk M, Lagerweij T, Koning F, et al. (2012) Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics. Inflammatory Bowel Diseases 18: 1424-1433.
17. Manolakis AC, Kapsoritakis AN, Tiaka EK, Potamianos SP, (2011) Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease. Digestive Diseases and Sciences 56: 1601-1611.
18. Arijs I, De Hertogh G, Machiels K, Van Steen K, Lemaire K, et al. (2011) Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment. The American Journal of Gastroenterology 106: 748-761.
19. Wirtz S, Neurath MF, (2007) Mouse models of inflammatory bowel disease. Advanced Drug Delivery Reviews 59: 1073-1083.
20. Strober W, (2008) Why study animal models of IBD? Inflammatory Bowel Diseases 14 (Suppl 2): S129-31.
21. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W, (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. The Journal of Experimental Medicine 182: 1281-1290.
22. Noble CL, Abbas AR, Cornelius J, Lees CW, Ho GT, et al. (2008) Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 57: 1398-1405.
23. Noble CL, Abbas AR, Lees CW, Cornelius J, Toy K, et al. (2010) Characterization of intestinal gene expression profiles in crohn's disease by genome-wide microarray analysis. Inflammatory Bowel Diseases 16: 1717-1728.
24. Gijsbers K, Geboes K, Van Damme J, (2006) Chemokines in gastrointestinal disorders. Current Drug Targets 7: 47-64.
25. Danese S, Sans M, de la Motte C, Graziani C, West G, et al. (2006) Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130: 2060-2073.
26. Zimmerman NP, Vongsa RA, Wendt MK, Dwinell MB, (2008) Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflammatory Bowel Diseases 14: 1000-1011.
27. Porter BO, Malek TR, (2000) Thymic and intestinal intraepithelial T lymphocyte development are each regulated by the gammac-dependent cytokines IL-2, IL-7, and IL-15. Seminars in Immunology 12: 465-474.
28. Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, et al. (2011) Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nature Medicine 17: 1585-1593.
29. Hallgren J, Gurish MF, (2011) Mast cell progenitor trafficking and maturation. Advances in Experimental Medicine and Biology 716: 14-28.
30. Stenton GR, Vliagoftis H, Befus AD (1998) Role of intestinal mast cells in modulating gastrointestinal pathophysiology. Annals of Allergy, Asthma & Immunology: Official Publication of the American College of Allergy, Asthma, & Immunology 81: 1-11; quiz 12-5.
31. Raithel M, Matek M, Baenkler HW, Jorde W, Hahn EG, (1995) Mucosal histamine content and histamine secretion in crohn's disease, ulcerative colitis and allergic enteropathy. International Archives of Allergy and Immunology 108: 127-133.
32. He SH, (2004) Key role of mast cells and their major secretory products in inflammatory bowel disease. World Journal of Gastroenterology: WJG 10: 309-318.
33. Andoh A, Deguchi Y, Inatomi O, Yagi Y, Bamba S, et al. (2006) Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease. Oncology Reports 16: 103-107.
34. Rijnierse A, Nijkamp FP, Kraneveld AD, (2007) Mast cells and nerves tickle in the tummy: Implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacology & Therapeutics 116: 207-235.
35. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, et al. (2012) Mast cells and inflammation. Biochimica Et Biophysica Acta 1822: 21-33.
36. Cunliffe RN, Rose FR, Keyte J, Abberley L, Chan WC, et al. (2001) Human defensin 5 is stored in precursor form in normal paneth cells and is expressed by some villous epithelial cells and by metaplastic paneth cells in the colon in inflammatory bowel disease. Gut 48: 176-185.
37. Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML, (2003) Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clinical and Experimental Immunology 131: 90-101.
38. Perminow G, Beisner J, Koslowski M, Lyckander LG, Stange E, et al. (2010) Defective paneth cell-mediated host defense in pediatric ileal crohn's disease. The American Journal of Gastroenterology 105: 452-459.
39. Sommers SC, (1966) Mast cells and paneth cells in ulcerative colitis. Gastroenterology 51: 841-850.
40. Boulton RA, Usselmann B, Mohammed I, Jankowski J, (2003) Barrett's esophagus: Environmental influences in the progression of dysplasia. World Journal of Surgery 27: 1014-1017.
41. Wehkamp J, Stange EF, (2006) Paneth cells and the innate immune response. Current Opinion in Gastroenterology 22: 644-650.
42. Zilbauer M, Jenke A, Wenzel G, Goedde D, Postberg J, et al. (2011) Intestinal alpha-defensin expression in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases 17: 2076-2086.
43. Strobel S, Miller HR, Ferguson A, (1981) Human intestinal mucosal mast cells: Evaluation of fixation and staining techniques. Journal of Clinical Pathology 34: 851-858.
44. Edgar R, Domrachev M, Lash AE, (2002) Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 30: 207-210.
45. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 3: Article3.
46. Psarros M, Heber S, Sick M, Thoppae G, Harshman K, et al. (2005) RACE: Remote analysis computation for gene expression data. Nucleic Acids Research 33: W638-43.